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Much of the US health care system relies on private physician practices. Little is known 
about the role of private equity in today’s health care delivery system. From 2010 to 2017, 
the value of private equity deals involving the acquisition of a health care–related company 
(most involving physician practices and hospitals) increased 187% and reached $42.6 
billion, while the number of health care deals increased by 48% (Figure).1 Given the 
increasing role of this type of financing, physicians and policy makers should understand 
private equity, common strategies used by its firms, and the potential risks and benefits for 
physicians and patients.
What Is Private Equity?
Private equity firms use capital from institutional investors to invest in private companies 
with potential to return a profit. That potential is realized if private equity firms manage to 
add value to the company and subsequently sell their stake at a price higher than the 
purchase, typically within 3 to 7 years. Private equity deals range from tens to hundreds of 
millions of dollars and are expected to deliver 20% to 30% returns. Private equity firms use 
several strategies to raise the value of practices, such as reducing costs (often through 
layoffs) and improving efficiency by consolidating and internalizing previously outsourced 
processes like billing. However, in physician practice acquisitions, key private equity tactics 
also include increasing prices and volume. Private equity firms typically purchase an 
established group practice and acquire smaller practices to establish regional brands that can 
exercise greater bargaining power with insurers and medical suppliers. As ownership shifts 
from physicians to private equity firms, more emphasis might be placed on extracting higher 
contracted payment rates, lowering overhead, and increasing volume and ancillary revenue 
streams (eg, imaging or procedures).
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Growth of Private Equity in Health Care
In 2017, the value of private equity deals in health care totaled $42.6 billion globally, up 
17% from 2016.1 The number of deals also increased to 265, from 206 in 2016. Health care 
deals comprised 18% of all private equity deals globally in 2017.1 Physicians, hospitals, and 
other facilities accounted for the most buyout activity, with 139 of the 265 health care 
private equity deals announced worldwide involving care delivery companies.1 Sectors of 
interest include retail health, behavioral health, free-standing medical centers (eg, for 
ambulatory surgery), and physician practice management, especially in highly paid 
specialties such as dermatology, ophthalmology, orthopedics, gastroenterology, urology, and 
allergy.
Several attributes of health care markets may help to explain why private equity investment 
in health care is increasing. First, groups that deliver care are often fragmented 
geographically, which allows private equity funds to consolidate market power and strive for 
economies of scale. Second, demand for health care is often considered recession resistant, 
with valuations remaining high despite turbulence in the economy. Third, the delivery 
system has numerous inefficiencies, which attracts private equity firms with a core 
competency of reducing waste. An aging population and the increasing prevalence of 
chronic disease also contribute to a growing demand for health care services.
Physicians may be attracted by private equity buyouts for several reasons, including the 
appeal of large upfront payments from the sale of their practice (often at double-digit 
multiples of earnings). These up-front payments are attractive because they replace future 
income but are taxed at capital gains rates, which are significantly lower than income tax 
rates. New requirements and mounting uncertainty as the health care system moves toward 
value-based purchasing may have also made physicians more interested in selling their 
practices. Some physicians may sell because of concern that they can no longer compete for 
insurance contracts as an independent practice in an increasingly consolidated market. Other 
motivating factors for physicians to sell include relief of financial pressures from increasing 
expenses for billing and technology and the opportunity to use an infusion of capital to grow 
the practice. These factors may outweigh any salary reductions or loss of autonomy from a 
buyout.
Potential Consequences
Although it may be premature to determine the consequences of increased private equity 
ownership on the health care system, the incentive structures and tactics of buyout firms 
raise concerns over the proliferation of private equity in health care. Evidence comparing the 
quality of private equity firm–owned practices with physician-owned practices is limited, 
due in part to nondisclosure agreements. However, the need for private equity firms to 
achieve high returns on investment (often at least 2.5×) on a fast time horizon 
(approximately 6 years on average) may conflict with the need for investments in quality and 
safety.2 Additionally, the need for generating returns may create pressure to increase 
utilization, direct referrals internally to capture revenue from additional services, and rely on 
care delivered by unsupervised allied clinicians.
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A case study in dermatology illustrates the risks of private equity in health care. 
Dermatologists, despite comprising 1% of physicians in the United States, were involved in 
approximately 15% of the more than 200 medical-practice acquisitions by private equity in 
2015 and 2016.3 Some have expressed concern that private equity ownership may create an 
emphasis on profitability, which influences patient care.3 In particular, dermatologists 
reported pressure to meet production numbers for procedures, sell products (eg, acne creams 
and antiaging products), and refer patients to affiliated specialists, laboratory technicians, 
and estheticians. Other concerns included upcharging in billing offices and significant 
reliance on physician assistants in unsupervised settings,3 which raises questions about 
patient safety and low-value care and highlights the importance of regulatory standards for 
medically necessary care and appropriate supervision of nonphysician clinicians.
Some specialties may be more susceptible than others. In ophthalmology, experience with 
private equity ownership and the effects on clinical practice appear to be mixed. While only 
qualitative evidence is available, some practices acquired by private equity firms report a 
short-term profit mentality that surpassed the need for long-term planning and equipment 
and facility requests; whereas others report little change in practice operations or patient 
care.4 The limited data and variability of anecdotal experience motivate the need for 
systematic study. The literature on private equity and nursing homes provides a model for 
research, including comparisons of quality between private equity–owned and independent 
nursing homes, as well as longitudinal case studies that document the operational changes 
following private equity buyout.5 One key concern for quality is that keeping referrals within 
the practice may render referral patterns less responsive to patient needs or preferences.
In light of increasing health care spending nationwide, the potential effects of private equity 
buyouts on spending deserve further study. Although hospital ownership of physician 
practices has been associated with higher prices and spending, private equity ownership has 
yet to be rigorously evaluated. As both hospitals and private equity firms benefit, under a 
fee-for-service model, from acquisitions that garner higher prices and higher volume 
(through internalizing referrals and ancillary revenue streams), private equity ownership may 
have similar effects as hospital or health system ownership of physician practices. However, 
given that hospitals and academic medical centers, unlike private equity firms, use revenues 
from some insurers to subsidize care for low-income patients and to fund medical education 
and research, private equity may have different implications for spending. Even though 
consolidation may create economies of scale and layoffs and other cost-cutting measures 
may reduce operating costs, increased market power over price negotiations with insurers 
and boosting volume for ancillary revenue streams may increase spending. Empirical 
analysis is needed to understand the net consequences and to compare spending among 
private equity–owned, hospital-owned, and independent practices.
In addition to quality and costs, there is reason to be concerned about access. After a private 
equity firm consolidates a fragmented market, it can use its market position to drive smaller 
independent practices out of business, potentially reducing the availability of physician 
services in a given geography. Another risk is that when a private equity firm sells recently 
acquired practices for a profit to new owners, some of those practices may be forced to 
declare bankruptcy. The struggles of physician practice management companies in the 1990s 
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is an important example of how financially motivated efforts to consolidate practices can 
lead to physician group bankruptcies.6 Private equity–owned practices may also face 
pressure from investors to avoid providing low-profit services.
Conclusions
Policy makers have an important role in the changing landscape of private equity and health 
care. First, because redirection of referrals and internalization of ancillary services are core 
strategies for boosting financial performance of physician practices, regulators could watch 
for violations of Stark Law, which prohibits physician self-referral for certain services, and 
the Antikickback Statute, which prohibits the use of incentives to encourage referrals among 
private equity–owned groups. Second, generating unnecessary volume and overreliance on 
allied practitioners without proper supervision may implicate the False Claims Act, which 
renders it illegal to submit fraudulent claims to Medicare or Medicaid, and possible 
malpractice. The Department of Justice recently pursued private equity firms that own health 
care companies in False Claims Act litigation.7 Third, given that private equity firms often 
consolidate practices in a region, regulators could monitor serial buyouts for anticompetitive 
consequences. Fourth, greater transparency over private ownership of physician practices 
may help patients make more informed choices about their care. This may also induce 
greater attention to quality among private equity owners of practices. These steps might help 
protect and empower patients, especially those in vulnerable populations.
The increase in private equity investments in health care poses risks, including 
overutilization, practice instability, and patient safety concerns. However, these investments 
may also benefit patients and bring more efficiency to a system burdened with waste. More 
research, and likely thoughtful regulation, are needed to preserve the positive effects of 
private equity in health care while mitigating the negative ones.
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Figure. Total Health Care Deal Value and Number of Deals, 2010-2017*
* Data from Bain Insights Report on Global Healthcare Private Equity and Corporate M&A 
Report 2018. Between 2010 and 2017, the total value of private equity deals in health care 
has increased 187% while the total number of private equity deals in health care has 
increased by 48%. Abbreviations: PE = private equity.
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